+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mens Health Diagnostics Market - Global Forecast 2026-2032- Product Image
Mens Health Diagnostics Market - Global Forecast 2026-2032- Product Image
Sale

Mens Health Diagnostics Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533359
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Mens Health Diagnostics Market is projected to reach USD 18.15 Billion in 2026. It is expected to continue growing at a CAGR of 11.69%, reaching USD 35.29 Billion by 2032.

Men's health diagnostics is moving from a narrow focus on symptomatic urology visits to a broader, evidence-driven model that supports preventive care, early detection, chronic disease management, fertility assessment, sexual health, and healthy aging. The category includes clinical chemistry, immunoassays, molecular diagnostics, imaging, digital risk stratification, at-home sample collection, and companion diagnostic pathways used across prostate health, hypogonadism, cardiovascular risk, metabolic disease, sexually transmitted infections, and male infertility.

The need is clinically urgent. Global health agencies consistently show that men have lower life expectancy than women in most countries and are less likely to use preventive healthcare services. At the same time, prostate cancer remains one of the most commonly diagnosed cancers among men worldwide, while diabetes, obesity, cardiovascular disease, and reproductive health concerns continue to increase demand for accessible, accurate, and patient-centered diagnostic solutions.

Transformative Shifts in the Diagnostics Landscape

The men's health diagnostics landscape is being reshaped by three connected shifts: earlier intervention, decentralized testing, and precision-guided care. Traditional, episodic testing is giving way to longitudinal health monitoring that combines laboratory data, imaging, risk scores, family history, and lifestyle indicators to identify disease earlier and guide personalized treatment decisions.

Regulatory and reimbursement environments are also changing. The European Union's In Vitro Diagnostic Regulation is raising evidence and quality expectations for diagnostic developers, while the United States is increasing oversight of laboratory-developed tests. These developments favor organizations with strong clinical validation, transparent analytical performance, cybersecurity controls, and real-world evidence strategies. Digital health, telemedicine, and at-home collection are further expanding access, particularly for men who delay clinic-based care due to stigma, time constraints, or limited local specialist availability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across men's health diagnostics by improving workflow efficiency, risk prediction, and clinical decision support. In prostate care, AI-enabled tools are being evaluated and adopted for prostate MRI interpretation, digital pathology, lesion detection, biopsy guidance, and prognostic modeling. In laboratory operations, AI supports quality control, anomaly detection, workflow prioritization, and faster result routing.

The highest-value use cases are not replacements for clinicians; they are systems that reduce variation, surface high-risk patients earlier, and support shared decision-making. However, adoption depends on explainability, prospective validation, bias monitoring, privacy compliance, and integration with electronic health records. Organizations that pair AI with rigorous governance can create measurable advantages in diagnostic accuracy, turnaround time, and patient engagement.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for men's health diagnostics, supported by large populations, rapid urbanization, expanding private healthcare, and rising chronic disease detection in China, India, Japan, South Korea, and Australia. Aging demographics in Japan, China, South Korea, and Australia are increasing demand for prostate health, cardiometabolic, and hormone-related testing, while India's scale and public digital health infrastructure are improving access to laboratory and teleconsultation services.

North America remains a leading region because of advanced laboratory networks, high diagnostic awareness, strong urology and oncology care pathways, and broad use of preventive testing in the United States and Canada. Latin America is advancing through private diagnostic chains and public health modernization, with Brazil and Mexico representing important demand centers despite uneven access. Europe benefits from aging populations, structured cancer pathways, and high clinical standards, while IVDR compliance is reshaping supplier strategies. The Middle East, especially the Gulf states, is investing in specialty care, screening, and digital health infrastructure. Africa remains underpenetrated but presents long-term potential through mobile health models, infectious disease testing infrastructure, and expanding urban diagnostic capacity.

Key Group Insights

ASEAN countries are expanding men's health diagnostics through a combination of universal coverage programs, private hospital growth, medical tourism, and improving laboratory networks. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines show different levels of maturity, but shared demand is rising for cardiometabolic screening, fertility testing, STI diagnostics, and cancer detection.

The GCC is a high-priority group due to elevated chronic disease burdens, strong healthcare investment, and national transformation programs that prioritize preventive care and digital health. The European Union is defined by harmonized but more demanding regulatory expectations under IVDR and strong data protection under GDPR. BRICS economies offer scale, manufacturing localization, and expanding middle-class demand, although access varies by reimbursement, infrastructure, and regulatory pathways. G7 countries remain central for innovation, clinical validation, and premium diagnostic adoption. NATO is not a healthcare trade bloc, but its member countries increasingly influence diagnostic supply chain resilience, cybersecurity expectations, and emergency preparedness standards.

Key Country Insights

The United States leads in advanced diagnostics, urology innovation, molecular testing, and AI-enabled imaging, while Canada emphasizes evidence-based adoption through provincial health systems. Mexico and Brazil are important Latin American markets, driven by private laboratory networks, urban specialist care, and rising demand for cancer and metabolic testing. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with established oncology and primary care pathways, while Russia retains demand for urology and chronic disease diagnostics despite supply and technology constraints.

China and India offer the largest volume opportunities, supported by expanding hospital systems, digital health adoption, and increasing awareness of preventive testing. Japan, South Korea, and Australia are mature Asia-Pacific markets with strong screening cultures, advanced imaging, and high-quality laboratory infrastructure. South Korea's routine health checkup ecosystem and Japan's aging society make both countries important for early detection, while Australia combines public health programs with a sophisticated private diagnostics sector.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated diagnostic pathways that connect PSA testing, prostate MRI, molecular tools, hormone panels, fertility assessment, cardiometabolic screening, and digital risk stratification into coherent men's health programs. Solutions should be designed for primary care, urology, oncology, and consumer-access settings, with clear guidance on when testing changes clinical decisions.

Commercial success will depend on regulatory readiness, reimbursement evidence, and patient experience. Organizations should invest in real-world evidence, AI governance, interoperable data systems, and privacy-first digital engagement. Partnerships with urologists, employers, pharmacies, telehealth providers, and regional laboratory networks can improve access and adherence. In emerging markets, affordability, sample logistics, and localized education are as important as technology performance.

Research Methodology

This executive summary is built on a structured research approach combining secondary source analysis, regulatory review, clinical guideline assessment, and market signal triangulation. Core references include public datasets and publications from the World Health Organization, International Agency for Research on Cancer, OECD, World Bank, national health agencies, and recognized regulatory authorities such as the U.S. FDA and European Commission.

The methodology emphasizes verified, data-backed insights rather than unsubstantiated market claims. Findings are evaluated across disease burden, demographic trends, regulatory change, reimbursement dynamics, healthcare infrastructure, diagnostic technology adoption, and competitive positioning. Qualitative interpretation is aligned with standards for executive-level market intelligence, including cross-validation of regional and country-level assumptions.

Conclusion

Men's health diagnostics is entering a period of accelerated transformation as preventive care, precision medicine, at-home access, and AI-enabled workflows converge. Demand is supported by aging male populations, persistent chronic disease burdens, increased awareness of prostate and reproductive health, and the need to reach men earlier in the care journey.

The strongest opportunities will favor organizations that combine clinical credibility with scalable access. Organizations that validate their tests, integrate data responsibly, adapt to regional regulatory requirements, and build patient-centered diagnostic pathways will be best positioned to support long-term growth in this evolving field.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Mens Health Diagnostics Market, by Diagnostic Type
7.1. Introduction
7.2. Hormonal Diagnostics
7.3. Fertility & Reproductive Diagnostics
7.4. Mental & Neurological Health Biomarkers
7.5. Metabolic & General Health Screening
8. Mens Health Diagnostics Market, by Test Type
8.1. Introduction
8.2. Imaging Systems
8.2.1. Computed Tomography
8.2.2. Magnetic Resonance Imaging
8.2.3. Nuclear Imaging
8.2.4. Ultrasound
8.2.5. X Ray
8.3. Laboratory Tests
8.3.1. Biomarker Assays
8.3.2. Genetic Testing
9. Mens Health Diagnostics Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Urine
9.4. Semen
9.5. Saliva
10. Mens Health Diagnostics Market, by Application
10.1. Introduction
10.2. Cardiovascular Diagnostics
10.3. Diabetes Monitoring
10.4. Prostate Cancer Diagnostics
10.5. Urological Disorder Diagnostics
11. Mens Health Diagnostics Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Diagnostic Centers
11.5. Hospitals
12. Mens Health Diagnostics Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Mens Health Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Mens Health Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. A3P Biomedical AB
16.2. Abbott Laboratories
16.3. Agilent Technologies, Inc.
16.4. Becton Dickinson and Company
16.5. Bio-Rad Laboratories, Inc.
16.6. bioMérieux SA
16.7. Danaher Corporation
16.8. DiaSorin S.p.A.
16.9. Exact Sciences Corporation
16.10. F. Hoffmann-La Roche Ltd
16.11. Hologic, Inc.
16.12. Horiba Ltd.
16.13. Johnson & Johnson Service, Inc.
16.14. Koninklijke Philips N.V.
16.15. Mindray Medical International Limited
16.16. Minomic International Ltd.
16.17. Myriad Genetics, Inc.
16.18. Natera, Inc.
16.19. Opko Health, Inc.
16.20. ProteoMediX AG
16.21. QIAGEN N.V.
16.22. Quest Diagnostics Incorporated
16.23. Randox Laboratories Ltd.
16.24. Siemens Healthineers AG
16.25. Sonic Healthcare Limited
16.26. Sysmex Corporation
16.27. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL X RAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL X RAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL X RAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL LABORATORY TESTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL LABORATORY TESTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BLOOD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL URINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL URINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SEMEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SEMEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SEMEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SALIVA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DIABETES MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DIABETES MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL DIABETES MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 110. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 111. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 112. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 113. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 114. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 115. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 126. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 127. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 128. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 129. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 135. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 136. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 137. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 138. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 139. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 141. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 143. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 144. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 145. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 146. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 147. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 157. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 158. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 159. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 160. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 161. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 162. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 163. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 164. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 167. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 168. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 169. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 170. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 171. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 175. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 176. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 177. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 178. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 179. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 184. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 191. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 192. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 193. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 194. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 195. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 196. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 197. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 199. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 200. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 201. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 202. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 203. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 204. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 205. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 207. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 208. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 209. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 210. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 211. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 224. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 225. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 226. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 227. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 228. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 229. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 230. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 231. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 232. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 233. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 234. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 235. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 236. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 237. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 239. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 240. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 241. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 242. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 243. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 244. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 245. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 248. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 249. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 250. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 251. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 252. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 256. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 257. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 258. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 259. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 260. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 261. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 262. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 264. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 265. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 266. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 267. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 268. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 269. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 271. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 272. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 273. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 274. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 275. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 276. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 277. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 278. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 279. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 280. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 281. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 282. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 283. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 284. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 285. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 287. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 288. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 289. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 290. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 291. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 292. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 293. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2017-2032 (USD MILLION)
TABLE 296. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2017-2032 (USD MILLION)
TABLE 297. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2017-2032 (USD MILLION)
TABLE 298. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2017-2032 (USD MILLION)
TABLE 299. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 300. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 301. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 303. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • A3P Biomedical AB
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Horiba Ltd.
  • Johnson & Johnson Service, Inc.
  • Koninklijke Philips N.V.
  • Mindray Medical International Limited
  • Minomic International Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Opko Health, Inc.
  • ProteoMediX AG
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 18.15 Billion
Forecasted Market Value ( USD ) by 2032 $ 35.29 Billion
Compound Annual Growth Rate11.6%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032 - Product Image

Prostate Cancer Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Prostate Cancer Diagnostics - Global Strategic Business Report - Product Image

Prostate Cancer Diagnostics - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Prostate Cancer Nuclear Medicine Diagnostics Market - Global Forecast 2026-2032 - Product Image

Prostate Cancer Nuclear Medicine Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Prostate Cancer Diagnostics Market Report by Type, Test Type,End User, Country and Company Analysis 2026-2034 - Product Image

Prostate Cancer Diagnostics Market Report by Type, Test Type,End User, Country and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From
Prostate Cancer Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Prostate Cancer Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.